Preliminary results from a pivotal Phase III trial of Alkermes Inc.'s Vivitrex indicate that a once-monthly injection, along with psychosocial therapy, helps men reduce their rate of heavy drinking. However, the drug does not appear to work as well in women. (BioWorld Today) Read More
